These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Make-up improves the quality of life of acne patients without aggravating acne eruptions during treatments. Hayashi N; Imori M; Yanagisawa M; Seto Y; Nagata O; Kawashima M Eur J Dermatol; 2005; 15(4):284-7. PubMed ID: 16048760 [TBL] [Abstract][Full Text] [Related]
43. Severe acne infantum successfully treated with isotretinoin. Torrelo A; Pastor MA; Zambrano A Pediatr Dermatol; 2005; 22(4):357-9. PubMed ID: 16060877 [TBL] [Abstract][Full Text] [Related]
44. A closer look at truncal acne vulgaris: prevalence, severity, and clinical significance. Del Rosso JQ; Bikowski JB; Baum E; Smith J; Hawkes S; Benes V; Bhatia N J Drugs Dermatol; 2007 Jun; 6(6):597-600. PubMed ID: 17668525 [TBL] [Abstract][Full Text] [Related]
45. Effects of tazarotene 0.1 % cream in the treatment of facial acne vulgaris: pooled results from two multicenter, double-blind, randomized, vehicle-controlled, parallel-group trials. Shalita AR; Berson DS; Thiboutot DM; Leyden JJ; Parizadeh D; Sefton J; Walker PS; Gibson JR; Clin Ther; 2004 Nov; 26(11):1865-73. PubMed ID: 15639698 [TBL] [Abstract][Full Text] [Related]
46. A community-based study of acne-related health preferences in adolescents. Chen CL; Kuppermann M; Caughey AB; Zane LT Arch Dermatol; 2008 Aug; 144(8):988-94. PubMed ID: 18711070 [TBL] [Abstract][Full Text] [Related]
47. Effect on quality of life in patients with pityriasis rosea: is it associated with rash severity? Chuh AA; Chan HH Int J Dermatol; 2005 May; 44(5):372-7. PubMed ID: 15869534 [TBL] [Abstract][Full Text] [Related]
48. [Recommendations for treatment of acne vulgaris]. Stögmann W Padiatr Padol; 1993; 28(3):A33-5. PubMed ID: 8367176 [TBL] [Abstract][Full Text] [Related]
52. Safety Considerations and Monitoring in Patients Treated with Systemic Medications for Acne. Park H; Skopit S Dermatol Clin; 2016 Apr; 34(2):185-93. PubMed ID: 27015778 [TBL] [Abstract][Full Text] [Related]
53. New insights into adolescent acne. Tom WL; Barrio VR Curr Opin Pediatr; 2008 Aug; 20(4):436-40. PubMed ID: 18622200 [TBL] [Abstract][Full Text] [Related]
54. Quality of life and acne in Scottish adolescent schoolchildren: use of the Children's Dermatology Life Quality Index (CDLQI) and the Cardiff Acne Disability Index (CADI). Walker N; Lewis-Jones MS J Eur Acad Dermatol Venereol; 2006 Jan; 20(1):45-50. PubMed ID: 16405607 [TBL] [Abstract][Full Text] [Related]
55. Current approach to acne management: a community-based analysis. Del Rosso JQ; Baldwin H; Keri J; Mancini A; Gold LS; Webster GF Cutis; 2009 Jun; 83(6 Suppl):5-21; quiz 22-4. PubMed ID: 19760893 [TBL] [Abstract][Full Text] [Related]
56. Acne in patients with skin of color: practical management. Yin NC; McMichael AJ Am J Clin Dermatol; 2014 Feb; 15(1):7-16. PubMed ID: 24190453 [TBL] [Abstract][Full Text] [Related]
57. Management of acne vulgaris with hormonal therapies in adult female patients. Husein-ElAhmed H Dermatol Ther; 2015; 28(3):166-72. PubMed ID: 25845307 [TBL] [Abstract][Full Text] [Related]
58. The noncompliant patient with acne. Tanghetti EA Skin Therapy Lett; 2011; 16(10):4-5. PubMed ID: 22337078 [TBL] [Abstract][Full Text] [Related]
59. Self-reported help-seeking behaviors and treatment choices of adolescents regarding acne. Corey KC; Cheng CE; Irwin B; Kimball AB Pediatr Dermatol; 2013; 30(1):36-41. PubMed ID: 22888857 [TBL] [Abstract][Full Text] [Related]